When At-Home Lecanemab Injections Is Not Helping Dementia: What Comes Next?

Learn when to stop at-home lecanemab, what scans and checks matter, and which dementia supports help next.

If at-home lecanemab shots no longer seem to help, bring the person back to the prescribing team for a stage and safety review. That visit decides whether to pause, stop, or continue treatment and shifts focus to daily support.

Worsening memory during treatment does not always mean the injections were done wrong. Lecanemab, sold as Leqembi, is an amyloid-targeting drug for early Alzheimer's disease. Eisai and Biogen announced FDA approval of weekly at-home starting treatment using two 250 mg autoinjector shots, after supervised training, according to the Eisai and Biogen approval announcement.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Why decline can continue during treatment

Lecanemab only slows decline. It does not cure Alzheimer's, reverse prior memory loss, or stop progression, the Dementia Society of America explains. Continued worsening can reflect that modest effect rather than a dosing mistake. In the 18-month Clarity AD trial in 1,795 early-Alzheimer's patients, decline slowed by 27% on the CDR-SB scale.

That was a mean difference of minus 0.45 points versus placebo, according to the BioArctic and Eisai trial summary. CDR-SB measures cognition and daily function together. A family may still see shorter memory, lost words, or more reminders. Slowing by less than half a point is hard to notice day to day. Compare months, not days, and bring notes on function, falls, behavior, and missed doses.

Is it still early Alzheimer's?

Leqembi is only for mild cognitive impairment or mild dementia due to Alzheimer's with confirmed elevated brain amyloid. The Alzheimer's Association describes this as the trial population, not moderate or severe dementia. Someone who has moved past that stage may no longer fit treatment. Ask what stage the doctor sees now.

Useful questions include recent test scores, daily-task changes, amyloid confirmation, and other causes of decline. Sleep loss, infection, depression, new drugs, and hearing change can also worsen thinking. If the diagnosis or stage has changed, do not restart shots at home to catch up. Let the clinic reset the plan. Home dosing only makes sense while the person still meets the early-Alzheimer's treatment group.

When should injections pause or stop?

German evidence agency IQWiG advises stopping lecanemab if disease reaches middle-stage moderate dementia. It also points to reassessment after about 18 months against burden and quality of life, information summarized by InformedHealth. That review weighs small slowing against visits, scans, side effects, and daily strain.

Safety scans can also force a pause. FDA labeling requires a recent baseline brain MRI plus scheduled MRIs for ARIA swelling or bleeding. It mandates suspending dosing for symptomatic or moderate-to-severe ARIA until MRI stabilization and symptom resolution guide resumption, according to the FDA package insert. Bring these items to the review:.

  • injection dates, missed doses, fevers, falls, headaches, confusion, vision changes, or bleeding
  • dates and results of baseline and follow-up brain MRIs
  • current drugs, alcohol use, blood thinners, and recent illness or anesthesia
  • examples of daily change in cooking, bills, driving, bathing, and wandering

What care helps after lecanemab stops?

Stopping lecanemab does not end dementia care. UK NICE guidance points to best supportive care plus symptom drugs, safety planning, caregiver support, and possible clinical-trial screening, according to the NICE draft consultation. The symptom options named are donepezil, galantamine, or rivastigmine for mild dementia and memantine for moderate-to-severe disease. Make daily life safer and simpler.

Lock medicines and cleaning products, add night lights and door alarms, simplify bills and meals, arrange transport, and set a regular sleep and activity routine. Ask the nurse, pharmacist, and social worker who handles each task. For caregivers, request respite hours, a crisis phone number, and help with legal, work, and driving decisions. Ask the clinic about trial screening at the same visit you discuss stopping, so eligibility testing can start while records and scans are current.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.